−2.15 TWD
−178.36 M TWD
2.54 M TWD
105.18 M
About GLYCONEX INCORPORATION
Sector
Industry
CEO
Mei Chun Yang
Website
Headquarters
New Taipei
Founded
2001
ISIN
TW0004168000
FIGI
BBG002B3T7J9
GlycoNex, Inc. engages in the anti-cancer monoclonal antibody development. It specializes in glycosphingolipid antigen production and identification, monoclonal antibody production, cancer drug screening, stable cell line production for monoclonal antibody, and pharmacology and pharmacokinetics assessment. The company was founded by Tong Hsuan Chang on February 1, 2001 and is headquartered in New Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4168 is 25.55 TWD — it has decreased by −1.73% in the past 24 hours. Watch GLYCONEX INCORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GLYCONEX INCORPORATION stocks are traded under the ticker 4168.
4168 stock has risen by 4.93% compared to the previous week, the month change is a 3.86% rise, over the last year GLYCONEX INCORPORATION has showed a −6.75% decrease.
4168 reached its all-time high on Dec 10, 2012 with the price of 152.05 TWD, and its all-time low was 10.15 TWD and was reached on Mar 23, 2020. View more price dynamics on 4168 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4168 stock is 2.35% volatile and has beta coefficient of 0.16. Track GLYCONEX INCORPORATION stock price on the chart and check out the list of the most volatile stocks — is GLYCONEX INCORPORATION there?
Today GLYCONEX INCORPORATION has the market capitalization of 2.76 B, it has increased by 2.05% over the last week.
Yes, you can track GLYCONEX INCORPORATION financials in yearly and quarterly reports right on TradingView.
4168 net income for the last quarter is −44.16 M TWD, while the quarter before that showed −50.02 M TWD of net income which accounts for 11.70% change. Track more GLYCONEX INCORPORATION financial stats to get the full picture.
No, 4168 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLYCONEX INCORPORATION EBITDA is −215.71 M TWD, and current EBITDA margin is −9.00 K%. See more stats in GLYCONEX INCORPORATION financial statements.
Like other stocks, 4168 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLYCONEX INCORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLYCONEX INCORPORATION technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLYCONEX INCORPORATION stock shows the sell signal. See more of GLYCONEX INCORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.